Clinical Trials on Dyslipidemia in Austria
Total 136 results
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
Chong Kun Dang PharmaceuticalCompleted
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Kowa Research Institute, Inc.Completed
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
AbbottCompletedHyperlipidemia | Mixed DyslipidemiaUnited States
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Medical University of ViennaUnknown
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, United States, Australia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
Bristol-Myers SquibbCompletedDyslipidemiaUnited States, Canada
-
AmgenCompletedDyslipidemiaUnited States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
-
Resverlogix CorpSouth Australian Health and Medical Research InstituteTerminatedCoronary Artery Disease | DyslipidemiaAustralia
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
AmgenCompletedDyslipidemiaUnited States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedDyslipidemiaUnited States
-
Bristol-Myers SquibbCompletedDyslipidemia | Diabetes Mellitus, Non-Insulin-DependentAustralia
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Australia, Italy, Spain, Sweden, Switzerland, Finland
-
AbbottCompletedDyslipidemiaUnited States
-
SanofiRegeneron PharmaceuticalsCompletedDyslipidemiaUnited States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Moritz OberndorferMerck Gesellschaft mbH, AustriaCompletedHIV Infections | Diabetes Mellitus | Dyslipidemias | Cardiovascular Risk FactorAustria
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaGreece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaboratorsCompletedGlucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | LipodystrophyAustralia
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
Mylan Inc.Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.CompletedHypercholesterolemiaGermany, Austria
-
Kowa Research Institute, Inc.Brigham and Women's HospitalTerminatedDyslipidemia | Type2 DiabetesUnited States, Spain, Canada, Hungary, Netherlands, Brazil, Bulgaria, Poland, Israel, Russian Federation, Ukraine, Denmark, Czechia, South Africa, Argentina, Mexico, United Kingdom, Romania, Germany, India, Slovakia, Japan, Colombia, ... and more
-
Medical University of ViennaMerck Sharp & Dohme LLC; European Foundation for the Study of Diabetes; Austrian... and other collaboratorsCompletedCardiovascular Disease | Diabetes | HypercholesterolemiaAustria
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
Marea TherapeuticsRecruiting
-
Medical University of ViennaUnknown
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedCardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular DiseaseFinland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
-
Medical University of ViennaUnknown